Getinge to Become CO₂Neutral by 2025

IN.PACT AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.

Martell Diagnostic Laboratories Announces HERTEST: Groundbreaking Way to Detect Effectiveness of Breast Cancer RX Globally

HERTEST is a blood test that looks for a protein called human epidermal growth factor receptor (HER2), which is shed into the blood stream of patients with growing breast cancer tumors.

ESPRIT CAM Improves Productivity for Long Part Machining by Automating Multi-spindle Program Creation

ESPRIT CAM: New computer-aided-manufacturing (CAM) technology has been introduced by ESPRIT CAM, part of Hexagon’s Manufacturing Intelligence division that provides manufacturers with the control and flexibility needed to use multi-spindle and multi-channel computer-numerical-control (CNC) machinery for the machining of long parts.

Getinge has announced its intention to become a CO₂neutral company by 2025. The target will be reached by a stepwise approach in several areas and supports the company’s objective to contribute to a sustainable health care environmentally as well as socially.

To secure long-term value-creation and competitiveness, sustainability is an integral part of the organization, actively working to minimize the negative environmental footprint. Getinge is committed to achieving the Paris agreement goals of limiting global warming to 1.5 °C above pre-industrial levels, and has now made the decision to become CO₂neutral by 2025.

“In 2012 we started changing the products’ environmental impact over the product life cycle through our EcoDesign principles”, says Mattias Perjos, President & CEO. “This covers all steps from the extraction of raw materials to production, distribution and use, all the way to recycling and disposal. Now we take this a step further, going all CO2 neutral”.

One product built on the EcoDesign principles is the S-8668T model in the 86-series Washer-Disinfectors. The S-8668T was developed to increase reprocessing throughput within the Central Sterile Supply Department (CSSD). With the turbo multitasking technology available for the S-8668T model, processing time can be cut by up to 25% and thereby reduce overall consumption of energy, water and chemicals.

“It is our responsibility to do our outmost to provide our customers with safe and sustainable products,” Mattias Perjos continues. “Within our product offering, we now have a number of products such as the steam sterilizer GSS610H, PowerLED II surgical light and the Flow family of anesthesia products that build on our EcoDesign.”

Equally important is Getinge’s work to significantly reduce its CO₂emissions in production. Between 2010-2018 the direct and indirect emissions were reduced by 29% (ton CO₂/MSEK).

To reach the new target to become a CO2 neutral company, Getinge has set-up various activities. For example, switching to renewable energy sources (green electricity) and investments in green certifications, but equally important to update the vehicle fleet, travel routines and finding new and smart logistics alternatives.

“The decision to become all CO₂neutral in five years’ time is a natural step for us and will be part of the entire organization’s operations,” says Mattias Perjos. “We will continuously analyze, validate and add activities related to our environmental efforts to ensure we reach our target.”

Getinge’s activities to become CO₂neutral will be externally validated through a third party auditor, PwC. To learn more about Getinge’s current Sustainability activities, please visit here.



Related Articles